Evaluation of implants coated with rhBMP‐2 using two different coating strategies: a critical‐size supraalveolar peri‐implant defect study in dogs
Authors:
- 14 May 2010
- journal article
- research article
- Published by Wiley in Journal of Clinical Periodontology
- Vol. 37 (6) , 582-590
Abstract
Lee J, Decker JF, Polimeni G, Cortella CA, Rohrer MD, Wozney JM, Hall J, Susin C, Wikesjö UME. Evaluation of implants coated with rhBMP‐2 using two different coating strategies: a critical‐size supraalveolar peri‐implant defect study in dogs. J Clin Periodontol 2010; 37: 582–590. doi: 10.1111/j.1600‐051X.2010.01557.x. Background: Implants coated with recombinant human bone morphogenetic protein‐2 (rhBMP‐2) induce relevant bone formation but also resident bone remodelling.Objectives: To compare the effect of implants fully or partially coated with rhBMP‐2 on new bone formation and resident bone remodelling.Materials and Methods: Twelve, male, adult, Hound Labrador mongrel dogs were used. Critical‐size, supraalveolar, peri‐implant defects received titanium porous oxide surface implants coated in their most coronal aspect with rhBMP‐2 (coronal‐load/six animals) or by immersion of the entire implant in an rhBMP‐2 solution (soak‐load/six animals) for a total of 30 μg rhBMP‐2/implant. All implants were air‐dried. The animals were euthanized at 8 weeks for histometric evaluation.Results: Clinical healing was uneventful. Supraalveolar bone formation was not significantly affected by the rhBMP‐2 application protocol. New bone height and area averaged (± SE) 3.4 ± 0.2 versus 3.5 ± 0.4 mm and 2.6 ± 0.4 versus 2.5 ± 0.7 mm2 for coronal‐load and soak‐load implants, respectively (p>0.05). The corresponding bone density and bone–implant contact (BIC) recordings averaged 38.0 ± 3.8%versus 34.4 ± 5.6% and 25.0 ± 3.8%versus 31.2 ± 3.3% (p>0.05). In contrast, resident bone remodelling was significantly influenced by the rhBMP‐2 application protocol. Bone density outside the implants threads averaged 74.7 ± 3.8% and 50.8 ± 4.1% for coronal‐load and soak‐load implants, respectively (ppConclusion: Local application of rhBMP‐2 appears to be a viable technology to support local bone formation and osseointegration. Coronal‐load implants obviate resident bone remodelling without compromising new bone formation.Keywords
This publication has 21 references indexed in Scilit:
- Alveolar ridge augmentation using implants coated with recombinant human growth/differentiation factor‐5: histologic observationsJournal of Clinical Periodontology, 2010
- Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein‐7 (rhBMP‐7/rhOP‐1): histological observationsJournal of Clinical Periodontology, 2010
- Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein‐2: histologic observationsJournal of Clinical Periodontology, 2008
- Bone formation at recombinant human bone morphogenetic protein‐2‐coated titanium implants in the posterior mandible (Type II bone) in dogsJournal of Clinical Periodontology, 2008
- Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein‐2: radiographic observationsClinical Oral Implants Research, 2008
- Bone formation at rhBMP‐2‐coated titanium implants in the rat ectopic modelJournal of Clinical Periodontology, 2007
- Bone reconstruction following implantation of rhBMP‐2 and guided bone regeneration in canine alveolar ridge defectsClinical Oral Implants Research, 2007
- The critical‐size supraalveolar peri‐implant defect model: characteristics and useJournal of Clinical Periodontology, 2006
- Trends in ProsthodonticsMedical Principles and Practice, 2006
- Hyaluronan Supports Recombinant Human Bone Morphogenetic Protein‐2 Induced Bone Reconstruction of Advanced Alveolar Ridge Defects in Dogs. A Pilot StudyJournal of Periodontology, 2001